Detalhe da pesquisa
1.
The prognostic value of lymph node staging with prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic lymph node dissection in node-positive patients with prostate cancer.
BJU Int;
131(3): 330-338, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36069585
2.
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.
BJU Int;
132(2): 170-180, 2023 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36748180
3.
WHO Classification of Tumours fifth edition: evolving issues in the classification, diagnosis, and prognostication of prostate cancer.
Histopathology;
81(4): 447-458, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35758185
4.
Risk factors associated with positive surgical margins' location at radical cystectomy and their impact on bladder cancer survival.
World J Urol;
39(12): 4363-4371, 2021 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34196758
5.
Gleason grade patterns in nodal metastasis and corresponding prostatectomy specimens: impact on patient outcome.
Histopathology;
75(5): 715-722, 2019 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31177561
6.
The World Health Organization 1973 classification system for grade is an important prognosticator in T1 non-muscle-invasive bladder cancer.
BJU Int;
122(6): 978-985, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29637669
7.
Biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam.
Int J Urol;
24(4): 281-286, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28173626
8.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet;
384(9959): 2027-35, 2014 Dec 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25108889
9.
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.
Mod Pathol;
28(5): 695-705, 2015 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25431236
10.
Prognostic significance of substage and WHO classification systems in T1 urothelial carcinoma of the bladder.
Curr Opin Urol;
25(5): 427-35, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26125511
11.
Validation of stem cell markers in clinical prostate cancer: α6-integrin is predictive for non-aggressive disease.
Prostate;
74(5): 488-96, 2014 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24375374
12.
An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps.
Histopathology;
63(6): 756-66, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24102813
13.
The predictive value of immunohistochemical markers in untreated Wilms' tumour: are they useful?
World J Urol;
31(4): 811-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21594709
14.
The Search for the Optimal cut-off Value of p53-Immunohistochemistry to Predict Prognosis of Invasive Bladder Cancer: A Multi-Center, Multi-Laboratory Analysis.
Int J Surg Pathol;
31(2): 157-166, 2023 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35466737
15.
International Opinions on Grading of Urothelial Carcinoma: A Survey Among European Association of Urology and International Society of Urological Pathology Members.
Eur Urol Open Sci;
52: 154-165, 2023 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37284047
16.
The FGFR3 mutation is related to favorable pT1 bladder cancer.
J Urol;
187(1): 310-4, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22099989
17.
Prognostic value of molecular markers, sub-stage and European Organisation for the Research and Treatment of Cancer risk scores in primary T1 bladder cancer.
BJU Int;
110(8): 1169-76, 2012 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22448597
18.
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients.
Urol Oncol;
40(3): 110.e1-110.e9, 2022 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34906411
19.
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume.
Mod Pathol;
24(1): 16-25, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20818340
20.
International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease.
Mod Pathol;
24(1): 26-38, 2011 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-20802467